Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (right eye)
ICD-10 E09.3411 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (right eye).
E09.3411 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by severe nonproliferative diabetic retinopathy with macular edema affecting the right eye. This condition arises when certain medications, such as corticosteroids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. The severe nonproliferative diabetic retinopathy indicates significant retinal damage, where the blood vessels in the retina are affected, leading to macular edema, which is the accumulation of fluid in the macula, causing vision impairment. Management of this condition often involves controlling blood glucose levels through insulin therapy or oral hypoglycemics, monitoring HbA1c levels to assess long-term glucose control, and addressing the ocular complications through ophthalmologic interventions. Regular follow-ups are crucial to prevent further deterioration of vision and to manage diabetes effectively.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with uncontrolled diabetes due to medication, requiring insulin therapy adjustments.
Ensure clear documentation of the drug responsible for diabetes and its management.
Detailed eye examination findings, including retinal imaging results.
Patients with diabetic retinopathy requiring laser treatment or injections.
Document the extent of retinopathy and any interventions performed.
Used for comprehensive eye exams in patients with diabetic retinopathy.
Document visual acuity, fundoscopic findings, and treatment recommendations.
Ophthalmologists should ensure detailed documentation of retinopathy severity.
Medications such as corticosteroids, certain antipsychotics, and some immunosuppressants can induce diabetes by affecting insulin sensitivity or secretion.
